Target intelligence / Profile preview

RNA, U6 small nuclear 132, pseudogene (RNU6-132P)

Target
RNU6-132P
Molecular classification
Pseudogene, Non-coding RNA-derived pseudogene, Other
01

Overview

RNU6-132P is a pseudogene copy of the gene encoding U6 small nuclear RNA, which itself is a non-coding RNA essential for the spliceosome’s function in pre-mRNA splicing[3][5]. Pseudogenes are faulty gene copies created during genome evolution—RNU6-132P contains sequence similarities to U6 snRNA but is assumed not to be transcribed or functional, and there is no evidence it produces RNA or protein[1][6]. The existence of multiple U6 pseudogenes in the genome is common and reflects the evolutionary significance of the original U6 snRNA gene, but these copies are generally inert[3][5]. There are no well-documented disease associations, biological functions, or known drug interactions for RNU6-132P. It is not considered a receptor, enzyme, transporter, or transcription factor, and should not be treated as a canonical therapeutic target or biomarker[1][6]. If you require a curated molecular target, refer to the functional U6 snRNA gene (not its pseudogene derivatives), or other canonical drug targets.

Other names
RNU6-132PRNA, U6 small nuclear 132, pseudogene
02

Mechanism of action

None (no drugs target RNU6-132P)

03

Biological functions

None known for this individual pseudogene.Other (pseudogenes may affect gene regulation through non-coding RNA mechanisms, but specific functions for RNU6-132P are not documented).
04

Disease associations

None reported specifically for RNU6-132POther pseudogenes may be differentially expressed in cancers and other diseases, but RNU6-132P is not listed among those with documented significance
05

Safety considerations

None relevant (as it is not a therapeutic target)
06

Interacting drugs

None
07

Biomarkers

None known or used in clinical or research settings for RNU6-132P

Beyond the preview

Go deeper on RNA, U6 small nuclear 132, pseudogene (RNU6-132P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 132, pseudogene (RNU6-132P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call